Ciara Veal
Family · Houston, TXNPI 1558726778
Payments from drug & device makers
Across 857 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Corium, LLC$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $7K from 25 others
What the payments were for
- Food & beverage$17,15899%
- Education$1801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 137 | $2,665 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 107 | $2,207 |
| Corium, LLC | 85 | $1,751 |
| Johnson & Johnson | 50 | $1,233 |
| Alkermes, Inc. | 61 | $1,150 |
| Otsuka America Pharmaceutical, Inc. | 43 | $1,089 |
| Bausch Health US, LLC | 45 | $874 |
| Lundbeck LLC | 35 | $799 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $736 |
| Tris Pharma Inc | 48 | $735 |
| Axsome Therapeutics, Inc. | 36 | $662 |
| Supernus Pharmaceuticals, Inc. | 35 | $587 |
| Teva Pharmaceuticals USA, Inc. | 10 | $375 |
| Ironshore Pharmaceuticals Inc. | 18 | $372 |
| Almatica Pharma LLC | 18 | $337 |
| Neos Therapeutics, LP | 15 | $268 |
| Sunovion Pharmaceuticals Inc. | 18 | $265 |
| E.r. Squibb & Sons, L.L.C. | 9 | $238 |
| Indivior Inc. | 8 | $186 |
| Eisai Inc. | 8 | $156 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| Noven Therapeutics, LLC | 7 | $130 |
| Neurocrine Biosciences, Inc. | 3 | $86 |
| Idorsia Pharmaceuticals US Inc | 4 | $70 |
| Vertical Pharmaceuticals, LLC | 3 | $52 |
| Noven Pharmaceuticals, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Quillichew ER$125
- Quillivant$125
- Dyanavel XR$125
- VRAYLAR$125
- INVEGA TRINZA$124
- INVEGA SUSTENNA$124
- Austedo XR$122
- REXULTI$120
- Azstarys$119
How this compares
$17,337 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 33 | $2,119 |
| Bupropion XlBupropion Hcl | 64 | $1,838 |
| Fluoxetine Hcl | 45 | $1,697 |
| Alprazolam | 120 | $1,027 |
| Duloxetine Hcl | 33 | $933 |
| Trazodone Hcl | 40 | $729 |
| Hydroxyzine Hcl | 18 | $696 |
| Buspirone Hcl | 23 | $557 |
| Quetiapine Fumarate | 46 | $501 |
| Aripiprazole | 19 | $467 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $456 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $441 |
| Clonazepam | 58 | $414 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $295 |
| Gabapentin | 19 | $289 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.